Search results
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant...
Benzinga· 16 hours agoBeyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease
The ‘100-day cough’ can be lethal in babies – so what is behind its global rise?
Daily Telegraph· 5 hours agoThe ‘100-day cough’ – known clinically as pertussis – infects the lungs and respiratory system,...
America’s Infectious-Disease Barometer Is Off
The Atlantic· 2 days agoThe ongoing outbreak of H5N1 avian flu virus looks a lot like a public-health problem that the United States should be well prepared for. Although this...
Bird flu vaccines are ready, milk is safe, and 3 other updates
Becker’s Hospital Review· 14 hours agoThe U.S. has two vaccines ready to circulate if bird flu begins spreading easily to humans, with doses that could begin shipping widely within weeks, if needed, NBC News reported May 1. Both ...
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon via Yahoo News· 5 days agoIt also mitigated contact transmission of SARS-CoV- 2 between hamsters...in animals by creating a...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo Finance· 1 day ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from...
Nature· 6 days agoWhile all AAV-mAbs provided protection, AAV-αPcrV and AAV-MEDI3902 provided 100% and 87.5% protection from a lethal challenge with 4.47 × 107 CFU PAO1 and ...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 2 days agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 16 hours agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 1 day agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
